AVBH(AVBH)
AVBH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $117M | $130M |
| Low | $116M | $129M |
| High | $118M | $131M |
| EBITDA Avg | $-9M | $-10M |
| Low | $-9M | $-10M |
| High | $-9M | $-10M |
| EBIT Avg | $-11M | $-12M |
| Low | $-11M | $-12M |
| High | $-11M | $-12M |
| Net Income Avg | $26M | $29M |
| Low | $26M | $29M |
| High | $27M | $30M |
| EPS Avg | $3.42 | $3.81 |
| Low | $3.34 | $3.78 |
| High | $3.50 | $3.85 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $30M | $31M | $31M | $32M | $33M | $34M |
| Low | $29M | $30M | $30M | $31M | $33M | $34M |
| High | $30M | $31M | $31M | $32M | $34M | $34M |
| EBITDA Avg | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M |
| Low | $-2M | $-2M | $-2M | $-2M | $-3M | $-3M |
| High | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M |
| EBIT Avg | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M |
| Low | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M |
| High | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M |
| Net Income Avg | $9M | $10M | $9M | $10M | $11M | $11M |
| Low | $9M | $9M | $9M | $10M | $10M | $11M |
| High | $10M | $10M | $10M | $10M | $11M | $11M |
| EPS Avg | $0.86 | $0.89 | $0.88 | $0.94 | $0.98 | $1.01 |
| Low | $0.83 | $0.88 | $0.87 | $0.92 | $0.96 | $1.00 |
| High | $0.90 | $0.90 | $0.89 | $0.95 | $0.99 | $1.03 |
| Analysts (Rev / EPS) | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |